The page is the record's research on the issuer — no analyst, no rating, no view. # EUPRAXIA PHARMACEUTICALS INC. (NASDAQ: EPRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing EUPRAXIA PHARMACEUTICALS INC. is listed on NASDAQ under the ticker EPRX, with ISIN US29842P1057. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-A1). The security type is Non-operating entity type (other), the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The listing status is listed, not halted. ## The disclosure read The record holds 46 filings in the twelve months to 2026-11-08, across 36 filing days: 2 prospectus, 13 regulatory filing and 31 results. The median gap between filing days is 6 days. The latest filing is a results filing dated 2026-10-22, 17 days before the record date. The exchange median is 6.0 days cadence, 52 filings and 5.0 days latency, across 4359 issuers. The sector median is 6.0 days cadence, 63.0 filings and 4.0 days latency, across 526 issuers. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under the rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, chapter as of 2026-11-04, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001581178.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/EPRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/EPRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/EPRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp